Carnegie acted as lead manager in the secondary placement of shares in Karo Bio. Karo Bio develops drugs based on nuclear receptor mechanisms.February, 2001.
Healthcare
Secondary placement of shares in Karo Bio (SE) — SEK 96 million
March 2001